Get started
Author

Omar Rashdan

Observed names: O Rashdan, O. Rashdan, Rashdan, Omar
ORCID: 0000-0002-5192-4823
Observed ORCID: 0000-0002-5192-4823
OpenAlex ID: A5057983355
The economic impact of tobacco smoking and secondhand smoke exposure in Jordan: estimating the direct and indirect costs
2024 · Nimer S. Alkhatib, Eman Massad, et al. · Journal of Medical Economics · 11
Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan
2023 · Hala H. Halawah, Nimer S. Alkhatib, et al. · Journal of Medical Economics · 10
PDF
Estimating the indirect economic burden of cancer in Jordan: a retrospective observational study
2024 · Omar Rashdan · BMJ Open · 9
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective
2023 · Shiraz Halloush, Nimer S. Alkhatib, et al. · Annals of Pharmacotherapy · 7
Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective
2024 · Nimer S. Alkhatib, Abdulaali R. Almutairi, et al. · PLoS ONE · 3
Economic sustainability in Jordan: a comparative machine learning analysis of current economic growth drivers
2025 · Omar Rashdan, Mutaz AlShafeey · Middle East Development Journal · 1
Can Jordan's New HTA Reference Case Be Met? Assessing the Transferability of Regional NCD Evidence
2026 · Omar Rashdan, Osama Samawi, et al. · Open Science Framework
EE411 Budget Impact Analysis of Subcutaneous Infliximab (CT-P13 SC) for Treating Inflammatory Bowel Disease in Saudi Arabia: Analysis from Payer Perspective
2024 · H Abumansour, N Alkhatib, et al. · Value in Health
PDF
EPH133 Real-World Effectiveness of Osimertinib in Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutation: Systematic Review and Meta-Analysis
2023 · A. Almutairi, N. Alkhatib, et al. · Value in Health
PDF
Works count: 13
Citation count: 41
H-index: 4
I10-index: 2
Year
Topic
Type